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doi:10.1016/j.pedneo.2012.04.007Background: Few published studies have explored the clinical manifestations of nontyphoid
salmonellosis in children <2 years of age. The aim of this study was to investigate the clinical
manifestations, microbiological features, complications, fecal excretion time, and responses
to treatment in children <2 years of age with nontyphoid salmonellosis.
Methods: Between January 2005 and December 2009, pediatric patients who were admitted to
Kaohsiung Veterans General Hospital with positive cultures for nontyphoid Salmonella were
enrolled. The following data were recorded: demographic, clinical, and microbiological
features, underlying diseases, treatment regimen, complications, responses to treatment,
and fecal excretion time. The clinical manifestations were compared between patients <2
years of age and patients >2 years of age.
Results: Of a total 279 enrolled patients, 179 were >2 years of age. Compared with the
patients who were 2 years of age, patients <2 years of age demonstrated a significantly high-
er incidence of bloody stool, mixed infection, extraintestinal infection, longer course of anti-
biotics, longer course of diarrhea after admission, and more days spent in the hospital. The
rates of insusceptibility of nontyphoid Salmonella to ampicillin, chloramphenicol, trimetho-
prim/sulfamethoxazole, ceftriaxone, and ciprofloxacin in patients <2 years of age were
37.87%, 29.09%, 23.73%, 3.26%, and 2.25%, respectively. Younger patients were generally moreof Pediatrics, Veterans General Hospital-Kaohsiung, 386, Ta-Chung First Road, Kaohsiung, Taiwan.
om (C.C. Chiou).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
194 I-F. Huang et alsusceptible to antibiotics than patients 2 years of age, although this result was not statisti-
cally significant.
Conclusion: The clinical manifestations of nontyphoid salmonellosis are more severe in
younger children <2 years of age than older children. Local susceptibility patterns could serve
as a guide for the prescription of antibiotics by clinicians.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Nontyphoid Salmonella is widely spread throughout nature
and is the cause of an ongoing worldwide pandemic of
foodborne infections.1 Nontyphoid Salmonella can survive
in a wide range of hosts and is strongly associated with
agricultural products.2 In Taiwan, nontyphoid Salmonella
infection is also rampant.3 Although most cases of gastro-
enteritis that are caused by nontyphoid Salmonella infec-
tion are self-limiting. Up to 8% of patients with nontyphoid
Salmonella gastroenteritis develop bacteremia, and of
these 5e10% develop localized infections.4,5 The risk of
developing a nontyphoid Salmonella infection and suffering
from complications is higher in patients at the extremes of
age and those who are immunocompromised, such as HIV-
positive patients or those with pathogens that block the
reticuloendothelial system. Shimoni et al postulated that
there are major differences in the predispositions, clinical
presentations, and clinical outcomes of children and adults
who are infected with Salmonella; nontyphoid Salmonella
bacteremia is usually secondary to gastroenteritis in chil-
dren, but it frequently presents as primary bacteremia in
adults.6 The incidence of extraintestinal nontyphoid
Salmonella infection in Israel demonstrates a U-shaped age-
related pattern, with increased risk at the extremes of age,
especially in patients<2 years of age or >80 years of age.7,8
Chiu et al found that being <3 years of age is one of the
characteristics of pediatric patients at high risk of having an
extraintestinal infection.9 Chao et al found that being >1
year of age is one of the risk factors associated with
intestinal perforation in pediatric patients with nontyphoid
Salmonella toxic megacolon.10 Chiu et al further indicated
that such complications are regulated through immune-
mediated responses, hence young infants are often
spared.11 Based on the aforementioned studies, we
hypothesized that there might be different clinical mani-
festations in children with nontyphoid salmonellosis
depending on age. Cross-talk between T and B cells is of
fundamental importance for the establishment of a solid
acquired immunity to salmonellosis.12 Children <2 years of
age are incapable of mounting a T cell-dependent immune
response to polysaccharide macromolecules.13 However,
with the exception of extraintestinal infection, very few
published studies have focused on the clinical manifesta-
tions in children <2 years of age with nontyphoid
salmonellosis.
The aim of this study was to investigate the clinical
manifestations, microbiological features, complications,
fecal excretion time, and response to treatment in young
children <2 years of age with nontyphoid salmonellosis.2. Material and Methods2.1. Study population and case definition
Between January 2005 and December 2009, all of the
pediatric patients who were admitted to Kaohsiung
Veterans General Hospital with positive cultures for non-
typhoid Salmonella were enrolled in the study. The
following data were retrospectively collected and recorded
using a standard case report form for each episode of
nontyphoid salmonellosis: demographic, clinical, and
microbiological features, underlying diseases, treatment
regimen, complications, and responses to treatment. The
decision to administer antibiotic treatment was at the
discretion of the attending physician, with no input from
the authors. The criteria for admission and discharge were
customary. Patients were admitted if they presented with
fever and diarrhea with any symptoms/signs of dehydration
or bloody stool. Fever was defined as >37.5C, as measured
by an ear thermometer. Diarrhea was defined as a decrease
in consistency (i.e., soft or liquid) and an increase in the
frequency of bowel movements to three stools per day, and
bloody stool was defined as any stool reported by the
parent or guardian as containing blood in one 24-hour
period. Patients were discharged when afebrile for >24
hours and when the symptoms/signs of dehydration had
resolved. Furthermore, examination of the fecal excretion
time was prospectively designed. After thorough explana-
tion to and agreement from the patients’ families,
repeated stool cultures were collected from some patients
on the day of discharge. Then, additional stool cultures
were collected every 5e7 days until two consecutive stool
cultures were negative. Fecal excretion time was defined
as the time from the first positive stool culture through the
first of two consecutive negative results.
2.2. Microbiological features
All isolates were cultured and identified according to
standard methods, with no major changes regarding the
policy for the identification of Salmonella. All isolates were
serotyped using the Wellcolex color Salmonella test (Murex,
Dartford, United Kingdom), then confirmed by slide agglu-
tination test using the O antiserum to detect the O antigen
(Bacto, Liverpool, NSW, Australia). The antimicrobial
susceptibility of the Salmonella isolates was examined
using the standard disc diffusion method. Resistance to
specific antimicrobials was based on reference interpretive
standards of the zone diameter.14
Table 1 Demographics, underlying conditions, and clin-
ical features of 297 patients with nontyphoid salmonella
enterocolitis.
% (n/total)
Sex (male/total) 58.9 (175/297)
Age (mo) (median; range) 19; 2e193
Underlying diseases 7.4 (22/297)
Congenital heart diseases 7/297
Prematurity 5/297
Kawasaki disease 4/297
Genitourinary anomaly 3/297
Neurological deficit 2/297
Others (Down syndrome,
Prader-Willi syndrome)
2/297
Clinical features
Fever 95.3 (283/297)
Diarrhea 96.3 (286/297)
Bloody stool 38.4 (114/297)
Dehydration 76.8 (228/297)
Seizure 3.0 (9/297)
Mixed infection 14.8 (44/297)
Aeromonas spp. 24/297
Staphylococcus aureus 10/297
Rotavirus 9/297
Adenovirus 3/297
Others (Bacillus cereus,
Plesiomonas shigellosis)
4/297
Extraintestinal infection 9.8 (29/297)
Blood 27/297
Urine 1/297
Joint fluid 1/297
Complications 8/297
Fecal excretion time (d)* 16.2
* Forty-five patients agreed to be followed until two consec-
utive stool cultures demonstrated negative results.
Nontyphoid salmonellosis in young children 1952.3. Nontyphoid salmonellosis in children<2 years
of age
Patients were further divided into two subgroups: patients
<2 years of age and patients >2 years of age. The following
data were collected: sex, fever, days with diarrhea before
admission, days with bloody stool and dehydration, labo-
ratory data, underlying diseases, mixed infection, compli-
cations, extraintestinal infection, use of antibiotics,
response to treatment including days with fever and diar-
rhea after admission, days spent in the hospital, and fecal
excretion time. All data were compared between the two
groups. Mixed infection was defined as the simultaneous
detection of a pathogen other than nontyphoid Salmonella
in the stool. Complications included toxic megacolon,
bowel perforation, septic arthritis, and upper gastrointes-
tinal (UGI) bleeding. Toxic megacolon was defined as the
clinical presentation of a toxic appearance with a high
spiking fever (>39C), dehydration, and marked colon
dilatation (colon diameter >1.5 times the width of the
vertebral body of the first lumbar spine [L1-VB]) on plain
abdominal X-ray films.
2.4. Statistical analysis
Clinical and laboratory data were entered into a computer
data base for analysis (SPSS 16.0 for Windows). Categorical
data were analyzed using the Chi-square or Fisher exact
test. Continuous variables were compared by using the t
test or the Mann-Whitney U test. A p value <0.05 was
considered statistically significant.
3. Results
3.1. Demographic and clinical features
Two hundred and ninety-seven consecutive patients were
enrolled in the study. The characteristics and clinical
manifestations of these patients are shown in Table 1. The
age distribution is shown in Figure 1, and themedian age was
19 months (range: 2e193 months old). Of all of the patients,
58.9% (175 of 297) were male. Twenty-two patients (7.4%)
presentedwith underlying diseases. Diarrhea and fever were
the most common clinical manifestations of nontyphoid
salmonellosis. Mixed infection was identified in 44 patients
(14.8%). In the patients with mixed infections, Aeromonas
sobria (11 of 297) was the most common pathogen, followed
by A hydrophila (10 of 297) and rotavirus (9 of 297). Twenty-
nine patients (9.8%) experienced extraintestinal infection.
In 27 of these patients, isolates were obtained from blood
samples; in addition, isolates were obtained from the urine
of one patient and from the joint fluid of one patient. Eight
patients had both positive blood and stool cultures. Eight
patients developed complications: five patients developed
toxic megacolon, one experienced colon perforation, one
developed septic arthritis, and one developed UGI bleeding.
Forty-five patients agreed to be followed until two consec-
utive stool cultures demonstrated a negative result, and the
mean fecal excretion time was 16.2 days. Of these patients,
23 patients were <2 years of age.3.2. Microbiological features
Salmonella enteritidis B caused 56.2% (167 of 297) of the
episodes reported here, followed by S enteritidis D (21.9%;
65 of 297), C1 (10.1%; 30 of 297), C2 (8.1%; 24 of 297), E
(1.4%; 4 of 297) and S choleraesuis (1.0%; 3 of 297). The
results of the isolates obtained from the different age groups
and different sites are shown in Figure 2. Of these isolates,
39.1% (108 of 276) were resistant to ampicillin, 34.5% (30 of
87) were resistant to chloramphenicol, and 24.1% (71 of 295)
were resistant to trimethoprim/sulfamethoxazole (TMP/
SMX). Seven isolates were intermediately resistant to cef-
triaxone, and six were resistant to ciprofloxacin. The anti-
biotic susceptibility of nontyphoid Salmonella in the
different age groups is shown in Table 2. Nineteen isolates
were resistant to more than three antibiotics.
3.3. Nontyphoid salmonellosis in children<2 years
of age
Of the total of 297 patients admitted with nontyphoid
salmonellosis, 179 patients were <2 years of age. When
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Figure 1 Number of cases and age distribution of nontyphoid salmonellosis in southern Taiwan.
196 I-F. Huang et alcompared with patients >2 years of age, significantly more
patients <2 years had bloody stool (46.9% vs. 25.4%,
p < 0.001), mixed infection (18.4% vs. 9.3%, p Z 0.031),
extraintestinal infection (16.9% vs. 2.8%, p < 0.001), expe-
rienced diarrhea for more days after admission (4.5 vs. 3.3
days, p < 0.001), received antibiotics treatment (62.0% vs.
47.5%, pZ 0.017), and required longer stays in the hospital
(8.6 vs. 6.8 days, p < 0.001). Furthermore, although it was
not statistically significant, a longer fecal excretion timewas
also noted in the group thatwas<2 years of age (19.9 vs. 12.3
days, p Z 0.227; Table 3). The nontyphoid Salmonella
isolates from the patients <2 years of age were generally
more susceptible to antibiotics than those from the patients
>2 years of age; however, this finding was not statistically
significant (Table 2).4. Discussion
Our study confirms the widely held assumption that non-
typhoid salmonellosis patients <2 years of age demonstrateFigure 2 Isolates obtained from diffesevere clinical manifestations, including a higher incidence
of bloody stool, mixed infection, extraintestinal infection,
and diarrhea after admission. Children <2 years also
demonstrated higher rates of complications (3.9% vs. 0.8%);
however, this result was not statistically significant, which
may be due to the small numbers of patients with compli-
cations. Early childhood is characterized by an increased
susceptibility to infectious diseases, and this has been
attributed to both the immaturity of the immune system at
birth and to the sluggish development of immunocompe-
tence during the postnatal and early childhood years. This
vulnerability to infections appears to be particularly
pronounced in relation to intracellular pathogens, reflect-
ing the functional immaturity of cell-mediated immunity.15
Furthermore, gastric hypoacidity, the home environment,
and intrafamiliar transmission also play roles the develop-
ment of nontyphoid salmonellosis in younger children.16e18
Antibiotics were prescribed more often to patients <2
years of age, which may also have resulted in the longer
hospital stays. Previous studies have revealed that the
antibiotic treatment of patients with nontyphoidrent age groups and different sites.
Table 2 Antibiotic susceptibility of nontyphoid Salmonella isolates obtained from different age groups.
<2 y/o 2 y/o p Total
Resistant Intermediate Resistant Intermediate Resistant Intermediate
Ampicillin 37.9% (64/169) 41.1% (44/107) 0.614 39.1% (108/276)
Chloramphenicol 29.1% (16/55) 43.8% (14/32) 0.242 34.5% (30/87)
Trimethoprim/
sulfamethoxazole
23.7% (42/177) 24.6% (29/118) 0.890 24.1% (71/295)
Ceftriaxone 3.3% (3/92) 6.8% (4/59) 0.433 4.6% (7/151)
Ciprofloxacin 2.3% (4/178) 1.7 (2/118) 1.000 2.0% (6/296)
Nontyphoid salmonellosis in young children 197salmonellosis may prolong, rather than limit, the fecal
shedding of these organisms.19,20 Fecal excretion time was
demonstrated to be more prolonged in younger chil-
dren.16,21 Although it was not statistically significant, fecal
excretion time was also longer in patients <2 years of age
in our study. The combined effect of antibiotic prescription
and age might have contributed to the longer fecal excre-
tion time in patients <2 years of age. Furthermore, the
mean fecal excretion time was 16 days in our study, which
is shorter than that reported in a previous study, where the
fecal excretion time was reported to be 7 weeks in children
<5 years of age.21 The factors that result in variations in
the fecal excretion time include the criteria for negativity
(e.g., consecutive, 2, 3, or more negative stool cultures),
specimen collection, methods of bacteriological analysis,
measurement of the duration of infection, etc.21 Further-
more, it was difficult to differentiate reinfection from
continuous fecal excretion because the stool cultures were
not collected every day in the previous studies or in this
study. The aforementioned study was performed 20e30
years ago. The standards for hygiene, sanitation, avail-
ability of safe water, and food preparation practices have
all been significantly improved since then. All of these
factors might have contributed to the shorter fecal excre-
tion time measured in our study.Table 3 Characteristics of the study patients according to ages
<2 y/o (n Z 179; m
Sex (male/total) 101/179
Duration of fever before admission (d) 2.3  0.2
Duration of diarrhea before admission (d) 2.5  0.2
Bloody stool 84/179
Dehydration 132/179
Absolute neutrophil count (/Cumm) 5081  208
C-reactive protein (mg/dL) 6.7  0.6
Underlying diseases 13/179
Duration of fever after admission (d) 2.8  0.2
Duration of diarrhea after admission (d) 4.5  0.2
Extraintestinal infection 26/154
Complications 7/179, 3.9%
Mixed infection 33/179
Duration of hospital stay (d) 8.6  0.4
With antibiotics 111/179
Fecal excretion time (d) 19.9  5.8 (n Z 23
* SEM: standard error of the mean.In our previous study, which was conducted at the same
institute 10 years ago, the rates of resistance of nontyphoid
Salmonella to ampicillin, chloramphenicol, and TMP-SMX
were 60.5%, 66.0%, and 46.1%, respectively.22 In the
present study, the rates of resistance of nontyphoid
Salmonella to ampicillin, chloramphenicol, and TMP-SMX
were 39.1%, 34.5%, and 24.1%, respectively, which are all
lower than those reported in our previous study. However,
the insusceptibility rate to ceftriaxone was higher in the
present study than that of the previous study (4.6% vs.
0.3%). A trend of increasing insusceptibility to ceftriaxone
has also been observed in northern Taiwan.23 However, the
susceptibility rate to ciprofloxacin has not obviously
changed in the past 10 years (2.0% vs. 2.0%) according to
the results of our studies. Furthermore, the nontyphoid
Salmonella isolates obtained from the patients <2 years of
age were generally more susceptible to antibiotics than
those obtained from the patients >2 years of age, although
statistical significance was not obtained for this result. The
prevalence of resistance among nontyphoid Salmonella
isolates may be consistent with the level of the antibiotics
used to treat humans and animals because nontyphoid
Salmonella is a zoonotic pathogen. Furthermore, some
resistance genes are located on the plasmids, and the
majority of the resistant isolates are usually coresistant to.
ean  SEM*) 2 y/o (n Z 118; mean  SEM) p
74/118 0.335
2.5  0.2 0.399
2.3  0.2 0.353
30/118 <0.001
96/118 0.160
5591  280 0.138
7.7  0.7 0.302
9/118 1.000
2.4  0.2 0.129
3.3  0.2 <0.001
3/109 <0.001
1/118, 0.8% 0.152
11/118 0.031
6.8  0.3 <0.001
56/118 0.017
) 12.3  1.9 (n Z 22) 0.227
198 I-F. Huang et almany other antibiotics. The ability of these mobile
elements to transfer within or between bacterial species is
associated with the rapid spread of antimicrobial resistance
among Enterobacteriaceae, including Salmonella.23e25
Younger children have less chance of being exposed to
antibiotics and the products of animal husbandry compared
with older children. The prevalence of resistance among
nontyphoid Salmonella in our study may have been caused
by the inappropriate use of antibiotics in medicine, veter-
inary medicine, and the food industry. Therefore, in addi-
tion to creating innovative methods to limit the
inappropriate use of antibiotics in animal feed, the usage of
extended-spectrum cephalosporins in children should also
be weighed against the development of resistance.
Continuous surveillance of antibiotic resistance may
provide additional data that could be used to help refine
recommendations for the treatment of nontyphoid
salmonellosis.
In conclusion, the clinical manifestations of nontyphoid
salmonellosis, including bloody stool, mixed infection,
extraintestinal infection, and duration of hospital stay, are
more severe in children <2 years of age than older children.
Whether the more severe manifestations are an indication
of antibiotic treatment remains undetermined. Local
susceptibility patterns could serve as a guide for the
prescription of antibiotics by clinicians.References
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